JNJ vs MKC · P/E 17, rev $49.37B vs P/E 8.4, rev $3.81B
Johnson & Johnson (JNJ) versus McCormick & Company Incorporated (MKC) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
McCormick & Company Incorporated (MKC) is a packaged foods company listed on US.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported MKC revenue for 2026-05-31 was $3.81B. Net income was $1.17B. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
Not investment advice. Open the JNJ and MKC stock pages for the full models.
Not investment advice.